223 related articles for article (PubMed ID: 32885029)
1. The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico.
Gómez-Álvarez E; Verdejo J; Ocampo S; Ponte-Negretti CI; Ruíz E; Ríos MM;
Int J Cardiol Heart Vasc; 2020 Aug; 29():100545. PubMed ID: 32885029
[TBL] [Abstract][Full Text] [Related]
2. Diet-related inflammation is positively associated with atherogenic indices.
Heidarzadeh-Esfahani N; Hajahmadi S; Pasdar Y; Darbandi M; Najafi F; Moradinazar M; Bonyani M; Feyz-BashiPoor R; Soltani S
Sci Rep; 2024 Jun; 14(1):13190. PubMed ID: 38851843
[TBL] [Abstract][Full Text] [Related]
3. Association of the
Bora K; Pathak MS; Borah P; Hussain MI; Das D
Balkan J Med Genet; 2017 Jun; 20(1):59-70. PubMed ID: 28924542
[TBL] [Abstract][Full Text] [Related]
4. The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease.
Li Y; Feng Y; Li S; Ma Y; Lin J; Wan J; Zhao M
Front Cardiovasc Med; 2023; 10():1140215. PubMed ID: 37441702
[TBL] [Abstract][Full Text] [Related]
5. Six Month Polypill Therapy Improves Lipid Profile in Patients with Previous Acute Myocardial Infarction: The Heart-Mex Study.
Méndez-García LA; González-Chávez A; Trejo-Millán F; Navarrete-Zarco HU; Carrero-Aguirre M; Meléndez G; Chávez A; Escobedo G
Arch Med Res; 2019 May; 50(4):197-206. PubMed ID: 31499480
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria.
Olamoyegun MA; Oluyombo R; Asaolu SO
Ann Afr Med; 2016; 15(4):194-199. PubMed ID: 27853034
[TBL] [Abstract][Full Text] [Related]
7. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women.
Wu TT; Gao Y; Zheng YY; Ma YT; Xie X
Lipids Health Dis; 2018 Aug; 17(1):197. PubMed ID: 30134981
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial.
Mostaza JM; Suárez-Fernández C; Cosín-Sales J; Gómez-Huelgas R; Brotons C; Araujo FP; Borrayo G; Ruiz E;
BMC Cardiovasc Disord; 2022 Dec; 22(1):560. PubMed ID: 36550424
[TBL] [Abstract][Full Text] [Related]
9. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
10. Lipid profile and atherogenic indices in patients with stable chronic obstructive pulmonary disease.
Markelić I; Hlapčić I; Rogić D; Rako I; Samaržija M; Popović-Grle S; Rumora L; Vukić Dugac A
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):153-161. PubMed ID: 32981798
[TBL] [Abstract][Full Text] [Related]
11. Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia.
Tien YT; Wang LJ; Lee Y; Lin PY; Hung CF; Chong MY; Huang YC
Schizophr Res; 2023 Dec; 262():95-101. PubMed ID: 37931565
[TBL] [Abstract][Full Text] [Related]
12. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.
Lorenzatti AJ; Monsalvo ML; López JAG; Wang H; Rosenson RS
Cardiovasc Diabetol; 2021 Apr; 20(1):94. PubMed ID: 33941192
[TBL] [Abstract][Full Text] [Related]
13. Traditional and Non-traditional Lipid Profiles in Bosnian Patients with Probable Alzheimer's Disease and Vascular Dementia.
Zaciragic A; Valjevac A; Dervisevic A; Fajkic A; Spahic S; Jadric R; Hasanbegovic I; Lepara O
Med Arch; 2022 Aug; 76(4):267-272. PubMed ID: 36313955
[TBL] [Abstract][Full Text] [Related]
14. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of nontraditional lipid parameters for intracranial and extracranial atherosclerotic stenosis: a hospital-based observational study in China.
Yu S; Yan L; Yan J; Sun X; Fan M; Liu H; Li Y; Guo M
Lipids Health Dis; 2023 Jan; 22(1):16. PubMed ID: 36709301
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile and atherogenic indices and their association with platelet indices in familial Mediterranean fever.
Çakırca G; Çelik MM
Turk Kardiyol Dern Ars; 2018 Apr; 46(3):184-190. PubMed ID: 29664424
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the atherogenic index of plasma as a potential biomarker for cardiovascular disease in schizophrenia.
Onen S; Taymur I
J Psychopharmacol; 2021 Sep; 35(9):1120-1126. PubMed ID: 34176366
[TBL] [Abstract][Full Text] [Related]
19. [The gender features of disorders of composition of lipids of blood serum in patients with chronic pathology of kidneys.].
Murkamilov IT; Aytabaiev KA; Fomin VV; Murkamilova ZA; Rayimjanov ZR; Redjapova NA; Yusupov FA; Aydarov ZA
Klin Lab Diagn; 2018; 63(3):152-158. PubMed ID: 30673194
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia and the Prevalence of Hypertension: A Cross-Sectional Study Based on Chinese Adults Without Type 2 Diabetes Mellitus.
Cheng W; Zhuang J; Chen S
Front Cardiovasc Med; 2022; 9():938363. PubMed ID: 35872884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
